AVEO Stock Recent News
AVEO LATEST HEADLINES
Does AVEO Pharmaceuticals (AVEO) have what it takes to be a top stock pick for momentum investors? Let's find out.
AVEO (AVEO) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Today, we put small oncology name AVEO Pharmaceuticals in the spotlight for the first time in three and a half years. The company is seeing good sales growth from its franchise drug that was approved in 2021 and is marching toward profitability as a company.
Here is how AVEO Pharmaceuticals (AVEO) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.
AVEO (AVEO) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Hans Vitzthum - LifeSci Advisors Michael Bailey - President & Chief Executive Officer Mike Ferraresso - Chief Commercial Officer Erick Lucera - Chief Financial Officer Jeb Ledell - Chief Operating Officer Conference Call Participants Stephen Willey - Stifel Colleen Kusy - Baird Arthur He - HC Wainwright Operator Good afternoon, and welcome to AVEO Oncology Second Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only.
AVEO is a mostly forgotten name that is seeing very good growth in their lead product FOTIVDA. Their share price has run lower from exuberant highs reached almost 5 years ago, even as their fundamentals and future seem to be getting more solid.
BOSTON, May 18, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced that members of its senior management team will participate in a fireside chat at the H.C. Wainwright Global Investment Conference on Wednesday, May 25, 2022 at 1:30 p.m. eastern time.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO ) Q1 2022 Earnings Conference Call May 5, 2022 8:00 AM ET Company Participants Hans Vitzthum – LifeSci Advisors Michael Bailey – President and Chief Executive Officer Mike Ferraresso – Chief Commercial Officer Erick Lucera – Chief Financial Officer Jeb Ledell – Chief Operating Officer Conference Call Participants Colleen Kusy – Baird Andrew Berens – SVB Securities Soumit Roy – Jones Research Swayampakula Ramakanth – H.C. Wainwright Operator Good morning, and welcome to AVEO Oncology First Quarter 2022 Financial Results Conference Call.